Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion

Employees walk near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park, Illinois, U.S., on Monday, July 14, 2014. Abbott Laboratories said it plans to sell its generic drug business for established markets to Mylan Inc., getting in return a share of the newly combined companies in a deal valued at about $5.3 billion. Photographer: Daniel Acker/Bloomberg via Getty Images
Employees walk near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park, Illinois, U.S., on Monday, July 14, 2014. Abbott Laboratories said it plans to sell its generic drug business for established markets to Mylan Inc., getting in return a share of the newly combined companies in a deal valued at about $5.3 billion. Photographer: Daniel Acker/Bloomberg via Getty Images
Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion
LICENTIE KOPEN
Hoe mag ik dit beeld gebruiken?
€ 475,00
EUR

GEGEVENS

Beperkingen:
Neem voor gebruik voor alle commerciële of promotiedoeleinden contact op met uw lokale kantoor.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credits:
Bloomberg / Contributor
Redactioneel nr.:
452152892
Collectie:
Bloomberg
Gemaakt op:
14 juli 2014
Datum van uploaden:
Soort licentie:
Release-informatie:
Geen release. Meer informatie
Bron:
Bloomberg
Naam materiaal:
ABBOTT MYLAN